It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar.
We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
.jpg)
It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar.
Amazon has just launched a digital pharmacy with discounts for paying US prime members. They currently serve 45 US states and are not yet available in Hawaii, Illinois, Kentucky, Louisiana, or Minnesota.
Why this is notable
Industry implications
Read more here.
We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.
We are so excited to hear of the new collaboration between our client Almirall and Finnish start-up Popit to promote medication adherence and support information dissemination to patients on their drug for plaque psoriasis called Skilarence [dimethyl fumarate].
Why this is notable
Industry implications
Medication adherence is a crowded space and some technologies have been more successful than others in prompting behaviour change. Popit’s technology is well tolerated and non-invasive, thus very promising.
Popit has clearly establishing itself as a major contender in this space, having established partnerships big pharma such as Pfizer and Novartis in recent years.
Read more here.
We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.
Aptar specialize in consumer dispensing, active packaging, drug delivery solutions and services. They have now acquired all operating assets and the proprietary portfolio of Cohero Health Inc. Cohero is FDA cleared for its smartphone-connected spirometer.
Why this is notable
Aptar has made previous investments in digital respiratory company Sonmol in China and digital health company Navia Life Care in India. With this strategic bolt on, Aptar now has global capabilities to deploy digital respiratory health, utilizing either the Cohero or Aptar device portfolio/platform.
Industry implications
Read more here.
Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.
Not yet a member of HealthXL? Download your 11 page snapshot of the report.
Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.
Join this series of 2 meetings to discuss with other senior leaders Commercialization Models & Adoption in Prescription DTx. Limited spaces available so apply now to secure your place in the conversation.
Join us in this informal conversation with senior leaders how DTx companies should think about Medtech as the appropriate partner and vice versa. Apply now to connect with peers and network with new people.
Do you want to learn from one of the top DTx companies in mental health? Join us in this exclusive fireside chat with Peter Hames, co-Founder and CEO at Big Health, where we will talk about the early days of DTx in mental health, Big Health’s differentiated commercialization models, industry leading clinical evidence and the significant opportunity to address the mental health crisis by expanding access to mental health care.
This series of 2 meetings to discuss in detail with other senior leaders the current state of DTx in mental health, what indications are best suited to such interventions, and commercial opportunities that they present. Perfect opportunity to listen, engage and enjoy.
Are you a HealthXL Member? See the Full Report Here
Non-HealthXL Member? You can purchase the report HERE
Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
Join this series of 2 meetings to discuss with other senior leaders Commercialization Models & Adoption in Prescription DTx. Limited spaces available so apply now to secure your place in the conversation.
Join us as we discuss commercialization models for Virtual Care in Cardiometabolic Diseases. Our 75 minute sessions are highly interactive and give attendees the opportunity to hear from senior leaders in the space and also share their own thoughts on the topic
Join us in this informal conversation with senior leaders how DTx companies should think about Medtech as the appropriate partner and vice versa. Apply now to connect with peers and network with new people.
Do you want to learn from one of the top DTx companies in mental health? Join us in this exclusive fireside chat with Peter Hames, co-Founder and CEO at Big Health, where we will talk about the early days of DTx in mental health, Big Health’s differentiated commercialization models, industry leading clinical evidence and the significant opportunity to address the mental health crisis by expanding access to mental health care.
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
